Function and mode of regulation of endothelial major histocompatibility complex class II

Cell Transplantation

Volumn 18, Issue 3, 2009, Pages 255-259

  Alexander, Irina ^a,b   Edelman, Elazer R ^a,c   Methe, Heiko ^a,d  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ETH ZURICH   (Switzerland)

^c HARVARD MEDICAL SCHOOL   (United States)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Endothelial cell; Matrix; MHC class II molecule

Indexed keywords

BETA3 INTEGRIN; CD51 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; POLYSTYRENE; TISSUE SCAFFOLD;

ACUTE GRAFT REJECTION; ANTIGEN EXPRESSION; ARTERY ENDOTHELIUM; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL GROWTH; CELL TRANSPLANTATION; CELLULAR IMMUNITY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE CULTURE; TISSUE ENGINEERING;

ANIMALS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTEGRINS; VASCULAR DISEASES;

EID: 67449093714     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909788534997     Document Type: Review

References (31)

1. Aumailley, M.; Smyth, N. The role of laminins in basement membrane function. J. Anat. 193(Pt. 1):1-21; 1998. (Pubitemid 28430138)
2. Bonetti, P. O.; Lerman, L. O.; Lerman, A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 23(2):168-175; 2003.
3. Centra, M.; Ratych, R. E.; Cao, G. L.; Li, J.; Williams, E.; Taylor, R. M.; Rosen, G. M. Culture of bovine pulmonary artery endothelial cells on Gelfoam blocks. FASEB J. 6(12):3117-3121; 1992.
4. Chang, C. C.; Hoying, J. B. Directed three-dimensional growth of microvascular cells and isolated microvessel fragments. Cell Transplant. 15(6):533-540; 2006.
5. Clark, E. A.; Brugge, J. S. Integrins and signal transduction pathways: The road taken. Science 268(5208):233-239; 1995.
6. Denton, M. D.; Davis, S. F.; Baum, M. A.; Melter, M.; Reinders, M. E.; Exeni, A.; Samsonov, D. V.; Fang, J.; Ganz, P.; Briscoe, D. M. The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection. Pediatr. Transplant. 4(4):252-260; 2000.
7. Erickson, A. C.; Couchman, J. R. Still more complexity in mammalian basement membranes. J. Histochem. Cytochem. 48(10):1291-1306; 2000.
8. Ferry, B.; Leszczinski, D.; Halttunen, J.; Hayry, P. Regulation by interferon-gamma and methylprednisolone of class II antigenicity and immunogenicity. Transplant. Proc. 19(1 Pt. 1):249-250; 1987.
9. Krieger, N. R.; Yin, D. P.; Fathman, C. G. CD4+ but not CD8+ cells are essential for allorejection. J. Exp. Med. 184(5):2013-2018; 1996.
10. Larsen, C. P.; Morris, P. J.; Austyn, J. M. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J. Exp. Med. 171(1):307-314; 1990.
11. Lechler, R. I.; Sykes, M.; Thomson, A. W.; Turka, L. A. Organ transplantation - how much of the promise has been realized? Nat. Med. 11(6):605-613; 2005.
12. Methe, H.; Edelman, E. R. Cell-matrix contact prevents recognition and damage of endothelial cells in states of heightened immunity. Circulation 114(1 Suppl.):I233-238; 2006.
13. Methe, H.; Edelman, E. R. Tissue engineering of endothelial cells and the immune response. Transplant. Proc. 38(10):3293-3299; 2006.
14. Methe, H.; Groothuis, A.; Sayegh, M. H.; Edelman, E. R. Matrix adherence of endothelial cells attenuates immune reactivity: Induction of hyporesponsiveness in allo- and xenogeneic models. FASEB J. 21(7):1515-1526; 2007.
15. Methe, H.; Hess, S.; Edelman, E. R. The effect of three-dimensional matrix-embedding of endothelial cells on the humoral and cellular immune response. Semin. Immunol. 20(2):117-122; 2008.
16. Methe, H.; Nugent, H. M.; Groothuis, A.; Seifert, P.; Sayegh, M. H.; Edelman, E. R. Matrix embedding alters the immune response against endothelial cells in vitro and in vivo. Circulation 112(9 Suppl.):I89-95; 2005.
17. Nathan, A.; Nugent, M. A.; Edelman, E. R. Tissue engineered perivascular endothelial cell implants regulate vascular injury. Proc. Natl. Acad. Sci. USA 92(18):8130-8134; 1995.
18. Nugent, H. M.; Edelman, E. R. Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury. J. Surg. Res. 99(2):228-234; 2001.
19. Nugent, H. M.; Edelman, E. R. Tissue engineering therapy for cardiovascular disease. Circ. Res. 92(10):1068-1078; 2003.
20. Nugent, H. M.; Groothuis, A.; Seifert, P.; Guerraro, J. L.; Nedelman, M.; Mohanakumar, T.; Edelman, E. R. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: A safety and efficacy study in the pig. J. Vasc. Res. 39(6):524-533; 2002.
21. Orr, A. W.; Sanders, J. M.; Bevard, M.; Coleman, E.; Sarembock, I. J.; Schwartz, M. A. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: A potential role in atherosclerosis. J. Cell Biol. 169(1):191-202; 2005.
22. Pescovitz, M. D.; Thistlethwaite, Jr., J. R.; Auchincloss, Jr., H.; Ildstad, S. T.; Sharp, T. G.; Terrill, R.; Sachs, D. H. Effect of class II antigen matching on renal allograft survival in miniature swine. J. Exp. Med. 160(5):1495-1508; 1984.
23. Pietra, B. A.; Wiseman, A.; Bolwerk, A.; Rizeq, M.; Gill, R. G. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J. Clin. Invest. 106(8):1003-1010; 2000.
24. Raines, E. W.; Koyama, H.; Carragher, N. O. The extracellular matrix dynamically regulates smooth muscle cell responsiveness to PDGF. Ann. NY Acad. Sci. 902:39-51; 2000.
25. Sahni, A.; Sahni, S. K.; Francis, C. W. Endothelial cell activation by IL-1beta in the presence of fibrinogen requires alphavbeta3. Arterioscler. Thromb. Vasc. Biol. 25(10):2222-2227; 2005.
26. SanMartin, A.; Borlongan, C. V. Cell transplantation: Toward cell therapy. Cell Transplant. 15(7):665-673; 2006.
27. Sayegh, M. H.; Turka, L. A.; Milford, E. L.; Carpenter, C. B. Mixed lymphocyte response-generated suppressor cell specificity in humans is major histocompatibility complex-restricted. Hum. Immunol. 26(4):281-287; 1989.
28. Shizuru, J. A.; Seydel, K. B.; Flavin, T. F.; Wu, A. P.; Kong, C. C.; Hoyt, E. G.; Fujimoto, N.; Billingham, M. E.; Starnes, V. A.; Fathman, C. G. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 50(3):366-373; 1990.
29. Turesson, C. Endothelial expression of MHC class II molecules in autoimmune disease. Curr. Pharm. Des. 10(2):129-143; 2004.
30. Xie, B.; Zhao, J.; Kitagawa, M.; Durbin, J.; Madri, J. A.; Guan, J. L.; Fu, X. Y. Focal adhesion kinase activates Stat1 in integrin-mediated cell migration and adhesion. J. Biol. Chem. 276(22):19512-19523; 2001.
31. Xu, Q. B.; Oberhuber, G.; Gruschwitz, M.; Wick, G. Immunology of atherosclerosis: Cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin. Immunol. Immunopathol. 56(3):344-359; 1990.